These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7105629)

  • 21. Alterations in the disposition of differently cleared drugs in patients with cirrhosis.
    Klotz U; Fischer C; Müller-Seydlitz P; Schulz J; Müller WA
    Clin Pharmacol Ther; 1979 Aug; 26(2):221-7. PubMed ID: 455890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of salivary concentration data to pharmacokinetic studies with antipyrine.
    Meffin PJ; Williams RL; Blaschke TF; Rowland M
    J Pharm Sci; 1977 Jan; 66(1):135-7. PubMed ID: 833730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic disposition of antipyrine in patients with lung cancer.
    Tschanz C; Hignite CE; Huffman DH; Azarnoff DL
    Cancer Res; 1977 Nov; 37(11):3881-6. PubMed ID: 908027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ranitidine does not impair oxidative or conjugative metabolism: noninteraction with antipyrine, diazepam, and lorazepam.
    Abernethy DR; Greenblatt DJ; Eshelman FN; Shader RI
    Clin Pharmacol Ther; 1984 Feb; 35(2):188-92. PubMed ID: 6319067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simplified approaches to the determination of antipyrine pharmacokinetic parameters.
    Scavone JM; Greenblatt DJ; Blyden GT; Harmatz JS; Graziano PJ
    Br J Clin Pharmacol; 1988 Jun; 25(6):695-9. PubMed ID: 3203041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of the functional status of hepatic microsomal enzymes in workers exposed to carbon dioxide and vinyl chloride by using the antipyrine test].
    Lutz W; Stankiewicz A; Krajewska B
    Med Pr; 1987; 38(3):157-66. PubMed ID: 3118136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of rate of hepatic metabolism in vitro and half-life for antipyrine in vivo in three species.
    McManus ME; Ilett KF
    Xenobiotica; 1979 Feb; 9(2):107-18. PubMed ID: 433309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum folic acid levels and antipyrine clearance rates in smokers and non-smokers.
    Nakazawa Y; Chiba K; Imatoh N; Kotorii T; Sakamoto T; Ishizaki T
    Drug Alcohol Depend; 1983 Apr; 11(2):201-7. PubMed ID: 6861617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
    Rivière JH; Back DJ; Breckenridge AM; Howells RE
    Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short term anti-tubercular drug therapy and hepatic microsomal enzyme activity. Antipyrine metabolism as an index.
    Hamide A; Sivagnanam G; Raveendran R; Adithan C; Sivaraman V; Chandrasekar S
    J Assoc Physicians India; 1990 Sep; 38(9):631-2. PubMed ID: 2266077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microsomal enzymes in patients with gastric carcinoma as determined by plasma half-life of antipyrine.
    Higuchi T; Nakamura T; Uchino H
    Gan; 1978 Dec; 69(6):753-6. PubMed ID: 750270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased values of antipyrine clearance in type IV hyperlipoproteinemia.
    Bedeleanu D; Trif I; Lötsch JC; Cucuianu MP
    Med Interne; 1986; 24(3):183-90. PubMed ID: 3775212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.
    Teunissen MW; Spoelstra P; Koch CW; Weeda B; van Duyn W; Janssens AR; Breimer DD
    Br J Clin Pharmacol; 1984 Nov; 18(5):707-15. PubMed ID: 6508980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample.
    Loft S; Nielsen AJ; Borg BE; Poulsen HE
    Xenobiotica; 1991 Jan; 21(1):33-46. PubMed ID: 2003365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The disposition of antipyrine and its metabolites in young and elderly healthy volunteers.
    Posner J; Danhof M; Teunissen MW; Breimer DD; Whiteman PD
    Br J Clin Pharmacol; 1987 Jul; 24(1):51-5. PubMed ID: 3620285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of single dose kinetics of imipramine, nortriptyline and antipyrine in man.
    Gram LF; Andreasen PB; Overo KF; Christiansen J
    Psychopharmacology (Berl); 1976 Oct; 50(1):21-7. PubMed ID: 827758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy and clinical utility of simplified tests of antipyrine metabolism.
    Farrell GC; Zaluzny L
    Br J Clin Pharmacol; 1984 Oct; 18(4):559-65. PubMed ID: 6487495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elimination of antipyrine from saliva as a measure of metabolism in man.
    Welch RM; DeAngelis RL; Wingfield M; Farmer TW
    Clin Pharmacol Ther; 1975 Sep; 18(3):249-58. PubMed ID: 1164815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antipyrine clearance in pneumonia.
    Sonne J; Døssing M; Loft S; Andreasen PB
    Clin Pharmacol Ther; 1985 Jun; 37(6):701-4. PubMed ID: 4006370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipyrine elimination in saliva after low-dose combined or progestogen-only oral contraceptive steroids.
    Chambers DM; Jefferson GC; Chambers M; Loudon NB
    Br J Clin Pharmacol; 1982 Feb; 13(2):229-32. PubMed ID: 7059420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.